Merck-Serono to launch clinic sales for Concor tablets

Merck Serono has a plan to set up its clinic teams to independently market Concor tablets (bisoprolol fumarate) in major five cities, such as Seoul, Pusan, Daegu, Daejeon and Honam.

So far, JW Pharma has co-marketed Concor in clinic sector.

Concor is a drug belonging to the group of beta blockers, a class of drugs used primarily in cardiovascular diseases.

Composed of renowned medical ...